Skip to main content
. Author manuscript; available in PMC: 2015 Feb 23.
Published in final edited form as: Angew Chem Int Ed Engl. 2014 Jul 30;53(47):12930–12935. doi: 10.1002/anie.201403936

Table 1.

Anticancer activity (72 h) and EGFR inhibitory potential.

Inhibition of cell growth [IC50 μm] EGFR inhibition [IC50, nm]
Compound A431 Calu3 H1975
erlotinib 2.6±0.8 0.74±0.02 >25 2[17]
L1 >25 3.5±0.1 20±4 1.34
L2 9.2±0.5 2.0±0.5 15±2 0.95
L3 >25 >25 >25 4.59